JP2013067643A5 - - Google Patents

Download PDF

Info

Publication number
JP2013067643A5
JP2013067643A5 JP2012271386A JP2012271386A JP2013067643A5 JP 2013067643 A5 JP2013067643 A5 JP 2013067643A5 JP 2012271386 A JP2012271386 A JP 2012271386A JP 2012271386 A JP2012271386 A JP 2012271386A JP 2013067643 A5 JP2013067643 A5 JP 2013067643A5
Authority
JP
Japan
Prior art keywords
spray container
composition
container according
mucosa
meloxicam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012271386A
Other languages
English (en)
Other versions
JP5681693B2 (ja
JP2013067643A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013067643A publication Critical patent/JP2013067643A/ja
Publication of JP2013067643A5 publication Critical patent/JP2013067643A5/ja
Application granted granted Critical
Publication of JP5681693B2 publication Critical patent/JP5681693B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (16)

  1. 水性エタノール溶液に溶解したメロキシカムまたは薬学的に許容されるその塩と、水酸化ナトリウムとを含む組成物と、
    計測バルブとを備える、
    スプレー容器。
  2. エアロゾルスプレー容器である、請求項１に記載のスプレー容器。
  3. ポンプスプレー容器である、請求項１に記載のスプレー容器。
  4. 前記組成物が噴射剤を含まない、請求項１〜３のいずれか１項に記載のスプレー容器。
  5. 前記組成物が生体接着剤を含む、請求項１〜４のいずれか１項に記載のスプレー容器。
  6. 前記組成物がホウ酸を含む、請求項１〜５のいずれか１項に記載のスプレー容器。
  7. 薬学的有効量のメロキシカムまたは薬学的に許容されるその塩の経粘膜ミストを非ヒト動物の口腔粘膜に送達する、請求項１〜６のいずれか１項に記載のスプレー容器。
  8. 体重１キログラム当り約０．０５ミリグラムから約５ミリグラムの投与量で前記組成物を送達する、請求項７に記載のスプレー容器。
  9. 前記非ヒト動物の口腔粘膜が、頬側粘膜、歯肉粘膜、舌粘膜、口蓋粘膜、咽頭粘膜、及び舌下粘膜から成る群から選択される１又は複数の口腔粘膜を含む、請求項７又は８に記載のスプレー容器。
  10. 前記口腔粘膜が頬側粘膜を含む、請求項９に記載のスプレー容器。
  11. 前記組成物中のメロキシカムの濃度が組成物の約０．０１重量パーセントから約１０重量パーセントである、請求項１〜１０のいずれか１項に記載のスプレー容器。
  12. 前記組成物中のメロキシカムの濃度が組成物の約０．０１重量パーセントから約１０重量パーセントであり、前記組成物中の水性エタノールの濃度が全組成物の約１５重量パーセントから約９９．９９９重量パーセントである、請求項１〜１０のいずれか１項に記載のスプレー容器。
  13. ７．５重量％から１５重量％のエタノールを含む、請求項１〜１２のいずれか１項に記載のスプレー容器。
  14. 前記非ヒト動物が、イヌ、ネコ、ウマ、ウシ、ブタ、ヒツジ、及び家禽から成る群から選択される、請求項７に記載のスプレー容器。
  15. 前記組成物が、メロキシカムに加えて更に少なくとも１種の治療薬を含む、請求項１〜１４のいずれか１項に記載のスプレー容器。
  16. 前記組成物が麻酔した動物への投与に好適である、請求項１〜１５のいずれか１項に記載のスプレー容器。
JP2012271386A 2005-02-17 2012-12-12 動物における障害を治療および予防するための薬剤組成物の経粘膜投与 Expired - Fee Related JP5681693B2 (ja)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US65396405P 2005-02-17 2005-02-17
US60/653,964 2005-02-17
US66192005P 2005-03-16 2005-03-16
US60/661,920 2005-03-16
US66418305P 2005-03-23 2005-03-23
US66418105P 2005-03-23 2005-03-23
US60/664,181 2005-03-23
US60/664,183 2005-03-23
US66493905P 2005-03-25 2005-03-25
US66493805P 2005-03-25 2005-03-25
US60/664,939 2005-03-25
US60/664,938 2005-03-25
US66552505P 2005-03-28 2005-03-28
US60/665,525 2005-03-28
US66988805P 2005-04-11 2005-04-11
US60/669,888 2005-04-11
US67065105P 2005-04-13 2005-04-13
US60/670,651 2005-04-13
US69394205P 2005-06-27 2005-06-27
US60/693,942 2005-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007556306A Division JP5577021B2 (ja) 2005-02-17 2006-02-17 動物における障害を治療および予防するための薬剤組成物の経粘膜投与

Publications (3)

Publication Number Publication Date
JP2013067643A JP2013067643A (ja) 2013-04-18
JP2013067643A5 true JP2013067643A5 (ja) 2013-12-05
JP5681693B2 JP5681693B2 (ja) 2015-03-11

Family

ID=36917071

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007556306A Expired - Fee Related JP5577021B2 (ja) 2005-02-17 2006-02-17 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
JP2012271386A Expired - Fee Related JP5681693B2 (ja) 2005-02-17 2012-12-12 動物における障害を治療および予防するための薬剤組成物の経粘膜投与

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007556306A Expired - Fee Related JP5577021B2 (ja) 2005-02-17 2006-02-17 動物における障害を治療および予防するための薬剤組成物の経粘膜投与

Country Status (7)

Country Link
US (3) US8097614B2 (ja)
EP (2) EP1848270B1 (ja)
JP (2) JP5577021B2 (ja)
AU (1) AU2006214166B2 (ja)
CA (1) CA2597956C (ja)
ES (1) ES2490595T3 (ja)
WO (1) WO2006089082A2 (ja)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
EP2015632B1 (en) * 2006-04-19 2015-12-02 Mist Pharmaceuticals, LLC Stable hydroalcoholic oral spray formulations and methods
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
US20080118441A1 (en) * 2006-11-19 2008-05-22 Washington Joseph A Compositions and methods for the treatment of gastrointestinal conditions
WO2008070795A2 (en) * 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
EP2101736A4 (en) * 2006-12-19 2012-09-19 Merial Ltd HOMOGENEOUS PAST AND GEL FORMULATIONS
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
US20090274722A1 (en) * 2007-01-29 2009-11-05 Ligums John E Therapeutic Composition for the Treatment of BPH and ED
WO2008094873A1 (en) * 2007-01-29 2008-08-07 Ligums John E Therapeutic bph composition
EA016247B1 (ru) 2007-04-19 2012-03-30 Мэри Кэй Инк. Топическая композиция для уменьшения темных кругов, отечности и отвисания кожи в области глаз человека и способ ее применения
CA2687085A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20100035886A1 (en) * 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
CA2639895C (en) * 2007-10-05 2014-06-10 David Rowland Energizing compositions comprising goji, red clover and polygonum multiflorum, and uses thereof
CA2735714A1 (en) * 2008-09-05 2010-03-11 Troy Laboratories Pty. Ltd. Treatment of neonate foals with meloxicam
WO2010065547A1 (en) * 2008-12-01 2010-06-10 Map Pharmaceuticals, Inc. Inhalation delivery methods and devices
FR2940120B1 (fr) * 2008-12-19 2012-07-13 Philippe Perovitch Formulation pour l'administration par voie trans-muqueuse de setrons
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
FR2940911B1 (fr) * 2009-01-13 2012-09-21 Philippe Perovitch Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
US8663709B1 (en) * 2009-08-31 2014-03-04 Fairhaven Health, Llc Composition and method for fertility therapy using nutritional supplements
KR101484382B1 (ko) * 2010-02-24 2015-01-19 조에티스 엘엘씨 수의학적 조성물
US20140255453A1 (en) * 2013-03-11 2014-09-11 Jaxsen's Llc Herbal ointment for musculoskeletal and joint-related conditions
MX2012012196A (es) * 2010-04-22 2013-02-27 Genesis Lab Inc Composiciones y metodos para el control de las moscas de arena y otros insectos que succionan la sangre.
US20130190252A1 (en) * 2010-05-18 2013-07-25 Pharmathen S.A. Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof
CN103260702B (zh) 2010-10-28 2018-07-27 帕西拉制药有限公司 非甾体类抗炎药的缓释制剂
US8840937B2 (en) * 2011-08-02 2014-09-23 Walter Joe FORD, JR. Composition and method for recovery from mild traumatic brain injury
NZ623643A (en) * 2011-10-14 2015-12-24 Troy Lab Pty Ltd Meloxicam based formulations for providing analgesia in sheep
CN107261152B (zh) 2011-11-29 2022-03-04 优奥斯私人有限公司 包含环糊精和疏水性药物的可注射药物组合物的防腐方法
PL2801373T3 (pl) 2011-12-21 2017-07-31 Meiji Seika Pharma Co., Ltd. Lek do podawania miejscowego w leczeniu zaburzeń połykania
AU2013252491A1 (en) * 2012-04-27 2014-11-06 Troy Laboratories Pty Ltd Combination meloxicam and xylazine therapy in animals
CN104619312A (zh) * 2012-05-24 2015-05-13 因诺制药有限公司 阿瑞匹坦注射制剂
AU2013204134B2 (en) * 2012-06-06 2017-02-02 Bayer New Zealand Limited Ectoparasitic Treatment Method and Composition
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
US20140288471A1 (en) * 2013-03-19 2014-09-25 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
KR102088662B1 (ko) * 2013-06-13 2020-03-13 메이지 세이카 파루마 가부시키가이샤 연하장애 개선용 의약품
US9974768B2 (en) 2013-06-13 2018-05-22 Meiji Seika Pharma Co., Ltd. Pharmaceutical for improving dysphagia
WO2015093923A1 (es) * 2013-12-19 2015-06-25 Castro Aldrete Jorge Isaac Composiciones veterinarias que comprenden un principio activo y un vehículo farmacéuticamente aceptable para su administración a través de mucosas
US9855227B2 (en) 2015-12-18 2018-01-02 The Procter & Gamble Company Quick dissolving diphenhydramine oral dosage form
US20170232050A1 (en) * 2016-02-16 2017-08-17 David ELLERY Herbal formulation for treating chronic fatigue syndrome
US11331271B2 (en) 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
WO2018094253A1 (en) 2016-11-18 2018-05-24 Pacira Pharmaceuticals, Inc. Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same
CA3066361A1 (en) 2017-06-07 2018-12-13 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
KR101816855B1 (ko) 2017-09-29 2018-02-21 서울시립대학교 산학협력단 상황버섯 추출물 또는 베타글루칸을 유효성분으로 함유하는 악취 저감용 조성물
US11511103B2 (en) 2017-11-13 2022-11-29 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
CN112004563B (zh) 2018-02-01 2024-08-06 施菲姆德控股有限责任公司 血管内血泵以及使用和制造方法
CA3115195A1 (en) * 2018-10-08 2020-04-16 Troikaa Pharmaceuticals Limited Oromucosal solutions of zolpidem or pharmaceutically acceptable salts thereof
US11478490B1 (en) 2021-03-30 2022-10-25 Epalex Corporation Fospropofol formulations
US11439653B1 (en) 2021-03-30 2022-09-13 Epalex Corporation Fospropofol formulations
US11628178B2 (en) 2019-03-26 2023-04-18 Epalex Corporation Fospropofol methods and compositions
US11547714B2 (en) 2020-02-05 2023-01-10 Epalex Corporation Fospropofol salts, methods and compositions
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
JP2023510341A (ja) * 2020-01-10 2023-03-13 トレビ セラピューティクス インコーポレイテッド ナルブフィン投与メソッド
US20220071946A1 (en) * 2020-03-03 2022-03-10 Alte Verde Llc Cannabis Treatment of Insomnia, Pain, and Skin Conditions
WO2021247283A1 (en) * 2020-06-04 2021-12-09 Amcyte Pharma, Inc. Delivery of aerosolized micromolar composition concentrations
CN111920805B (zh) * 2020-08-14 2021-11-19 山东省妇幼保健院 富马酸氯马斯汀在抗耐甲氧西林金黄葡萄球菌制剂中的应用
JP2024508686A (ja) * 2021-02-05 2024-02-28 エパレックス コーポレーション フォスプロポフォールの方法及び組成物

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (ja) 1962-05-24
US3551554A (en) 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3666182A (en) * 1970-04-24 1972-05-30 Chatten Drug & Chem Co Squeeze bottle with means for locating end of delivery tube
US3711606A (en) 1970-09-02 1973-01-16 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active steroidal agents with dmso
US3711602A (en) 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US4122978A (en) * 1975-06-18 1978-10-31 The Gillette Company Pressurized package for dispensing a product in a finely dispersed spray pattern with little dilution by propellant
SE7812207L (sv) 1977-12-01 1979-06-02 Welsh Nat School Med Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4186855A (en) * 1978-06-19 1980-02-05 Zotos International, Inc. Spray pump actuating and bottle holding device
CA1165240A (en) 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
ZA815698B (en) 1980-08-28 1983-04-27 Lilly Co Eli Intranasal formulation
JPS5758615A (en) 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
CA1208558A (en) 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3338978A1 (de) 1982-10-29 1984-05-03 Basf Ag, 6700 Ludwigshafen Verapamil und gallopamil und ihre physiologisch vertraeglichen salze zur resorptiven anwendung auf den schleimhaeuten des mundes, des nasen-rachen-raums und des rektums
US4557943A (en) 1983-10-31 1985-12-10 Advanced Semiconductor Materials America, Inc. Metal-silicide deposition using plasma-enhanced chemical vapor deposition
GB8522453D0 (en) 1985-09-11 1985-10-16 Lilly Industries Ltd Chewable capsules
DE3544692A1 (de) 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4689233A (en) 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US4713243A (en) 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
JPH0645538B2 (ja) 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
HU199678B (en) 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
US5128132A (en) 1988-11-22 1992-07-07 Parnell Pharmaceuticals, Inc. Eriodictyon compositions and methods for treating internal mucous membranes
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
JP2656338B2 (ja) 1989-01-31 1997-09-24 日東電工株式会社 口腔粘膜貼付製剤
US5011678A (en) 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
US5158761A (en) 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
DE4007705C1 (ja) 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
DE69129110T2 (de) 1990-05-10 1998-12-10 Bechgaard International Research And Development A/S, Hellerup Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole
US5370862A (en) 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
US5407663A (en) 1991-04-11 1995-04-18 Eisen; Drore Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents
JP3661131B2 (ja) 1992-02-20 2005-06-15 アスペン ファーマケア ヨーロッパ リミテッド 喫煙抑制具
AU685741B2 (en) 1992-12-04 1998-01-29 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
GB2285921A (en) * 1994-01-31 1995-08-02 Leilani Lea Sublingual administration of medicaments
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
EE03509B2 (et) 1995-06-27 2015-02-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5955098A (en) 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US5869082A (en) 1996-04-12 1999-02-09 Flemington Pharmaceutical Corp. Buccal, non-polar spray for nitroglycerin
EP0910339B1 (en) 1996-04-12 2005-02-02 Novadel Pharma Inc. Buccal polar spray
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030095926A1 (en) 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20050163719A1 (en) 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20040141923A1 (en) 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030077229A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20040136913A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030082107A1 (en) 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20030077228A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030190286A1 (en) 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20040136915A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030095927A1 (en) 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
EP1029536B1 (en) 1997-10-01 2007-11-28 Novadel Pharma Inc. Buccal non-polar spray
US20050002867A1 (en) 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
FI974578A (fi) * 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
US6184220B1 (en) 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
US6428814B1 (en) 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6413965B1 (en) * 1999-06-30 2002-07-02 Pfizer Inc. Compositions and treatment for diabetic complications
US6328035B1 (en) * 2000-05-09 2001-12-11 Iep Pharmaceutical Devices Inc. Pneumatic breath actuated inhaler
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
JP4922528B2 (ja) * 2000-06-27 2012-04-25 株式会社明治 膨化チョコレート含有中空菓子及びその製法
US20040204413A1 (en) * 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
TW200403072A (en) 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
GB0229808D0 (en) 2002-12-20 2003-01-29 Glaxo Group Ltd Novel compositions
US8512727B2 (en) 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA05009602A (es) * 2003-03-11 2005-11-08 Arakis Ltd Composiciones novedosas.
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与

Similar Documents

Publication Publication Date Title
JP2013067643A5 (ja)
JP2019014728A5 (ja)
JP2009298801A5 (ja)
ES2774302T5 (es) Composición y forraje que comprende ácidos grasos de cadena media
NZ731588A (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
EP2219626A4 (en) METHOD FOR MANUFACTURING DOSAGE FORMS FOR THE DELIVERY OF MEDICAMENTS AND PRODUCTS CONTAINING SAME
NZ585219A (en) Fast release solid formulation, preparation and use thereof
EP2105129A3 (en) Encapsulated Vaccines for the Oral Vaccination and Boostering of Fish and Other Animals
HRP20120856T1 (hr) Transmukozni veterinarski pripravak koji sadrži detomidin
CO6220902A2 (es) Formulacion en polvo del valganciclovir
SI2906213T1 (en) Veterinary method for easing noise sensitivity
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
JP2012515002A5 (ja)
JP2015513396A5 (ja)
JP2017532369A5 (ja)
BR112013016554A2 (pt) métodos e composições úteis para promover sono nos animais
WO2012033874A1 (en) Method of treating compulsive self-injurious behaviors
JP2009540846A5 (ja)
JP2012513411A5 (ja)
JP2012530709A5 (ja)
RU2432955C1 (ru) Средство для лечения желудочно-кишечных заболеваний животных
RU2011127038A (ru) Способ функционального кормления свиноматок и поросят
MX2021011550A (es) Formulaciones de pregabalina y uso de las mismas.
ES2526216T3 (es) Uso de azaperona para mejorar el rendimiento del crecimiento
RU2021131027A (ru) Составы прегабалина и их применение